Liu, Y.-H.; Chen, Y.-H.; Ko, C.-H.; Kuo, C.-W.; Yen, C.-C.; Chen, W.; Chong, K.-Y.; Chen, C.-M.
SOD3 and IL-18 Predict the First Kidney Disease-Related Hospitalization or Death during the One-Year Follow-Up Period in Patients with End-Stage Renal Disease. Antioxidants 2022, 11, 1198.
https://doi.org/10.3390/antiox11061198
AMA Style
Liu Y-H, Chen Y-H, Ko C-H, Kuo C-W, Yen C-C, Chen W, Chong K-Y, Chen C-M.
SOD3 and IL-18 Predict the First Kidney Disease-Related Hospitalization or Death during the One-Year Follow-Up Period in Patients with End-Stage Renal Disease. Antioxidants. 2022; 11(6):1198.
https://doi.org/10.3390/antiox11061198
Chicago/Turabian Style
Liu, Yu-Hsien, Yu-Hsuan Chen, Chi-Hua Ko, Chia-Wen Kuo, Chih-Ching Yen, Wei Chen, Kowit-Yu Chong, and Chuan-Mu Chen.
2022. "SOD3 and IL-18 Predict the First Kidney Disease-Related Hospitalization or Death during the One-Year Follow-Up Period in Patients with End-Stage Renal Disease" Antioxidants 11, no. 6: 1198.
https://doi.org/10.3390/antiox11061198
APA Style
Liu, Y.-H., Chen, Y.-H., Ko, C.-H., Kuo, C.-W., Yen, C.-C., Chen, W., Chong, K.-Y., & Chen, C.-M.
(2022). SOD3 and IL-18 Predict the First Kidney Disease-Related Hospitalization or Death during the One-Year Follow-Up Period in Patients with End-Stage Renal Disease. Antioxidants, 11(6), 1198.
https://doi.org/10.3390/antiox11061198
